Health
Alpha-ray missile therapy: Tumor cells attacked from intracellular region – Medical Xpress
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor…
A cancer-specific L-type amino acid transporter 1 (LAT1) is highly expressed in cancer tissues. Inhibiting the function of LAT1 has been known to have anti-tumor effects, but there has been limited progress in the development of radionuclide therapy agents targeting LAT1. Now, a multidisciplinary research team at Osaka University has established a targeted alpha-therapy with a novel drug targeting LAT1.
The researchers first produced the alpha-ray emitter 211Astatine, no easy task given that Astatine…
-
Business17 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
General19 hours agoFootballers and movie stars: PM’s Shanghai tourism push
-
Business18 hours agoNvidia reaches the $4 trillion mark. Can it hit $5 trillion in 2025?
-
Noosa News17 hours agoYIMBYs vs NIMBYs as the battle for affordable housing moves into your backyard